Combination drops may help patients challenged by multiple glaucoma meds
February 08, 2021
Drops can simplify dosing, improving adherence and ocular surface health
February 20, 2021
Arsham Sheybani, MD, offers insight on how his glaucoma patient management protocols have altered and the shift in subconjunctival surgery in light of the pandemic.
February 08, 2021
Drops can simplify dosing, improving adherence and ocular surface health
February 05, 2021
Intraocular drainage surgery may have a future for treating issues.
February 05, 2021
Consider ideas about outflow pathways, neuroprotection.
February 01, 2021
Once-daily corticosteroid treats pain, inflammation after surgery.
January 31, 2021
Results of a survey among ophthalmologists indicate that patients are receiving fewer examinations — with worsening glaucoma, says S. Fabian Lerner, MD, speaking at the Glaucoma 360 New Horizons Forum.
January 31, 2021
A new therapy provides noninvasive nighttime IOP control by programming the desired pressure into the device, explained John Berdahl, MD, during the New Horizons Forum.
January 31, 2021
Glaukos Corporation's COO Chris Calcaterra gives an update on the company's latest 24-month phase 2b data for its iDose TR sustained-release travoprost implant, next steps for securing FDA approval, and his outlook for 2021.
January 31, 2021
Oluwatosin U. Smith, MD, Glaucoma Associates of Texas, provides an update on optimization and surgical modifications of newer glaucoma surgeries.
January 30, 2021
Joseph F. Panarelli, MD, associate professor of ophthalmology, NYU Langone Medical Center, shares some clinical pearls for managing masquerade syndromes and determining when it is not glaucoma.